Oxygenta Pharmaceutical Ltd

BSE
OXYGENTAPH •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Oxygenta Pharmaceutical Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
40.98% Fall from 52W High
-25.6
TTM PE Ratio
Negative PE TTM
-29.7
Price to Book Ratio
Negative Price to Book
-5.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-0.4
RSI
RSI is mid-range
36.7
MFI
MFI is mid-range
46.2

Oxygenta Pharmaceutical Ltd shareholding Pattern

Promoter
29.7%
Public
70.2%
Promoter
29.7%
Public
70.2%
Promoter
29.7%
Public
70.2%
Promoter
26.8%
Public
73.2%
Promoter
9%
Mutual Funds
0.1%
Public
91%
Promoter
12.3%
Mutual Funds
0.1%
Public
87.6%

Oxygenta Pharmaceutical Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
31.60
10Day EMA
32.40
12Day EMA
32.60
20Day EMA
33.30
26Day EMA
33.60
50Day EMA
34.30
100Day EMA
34.50
200Day EMA
34.00
5Day SMA
32.00
10Day SMA
32.40
20Day SMA
33.90
30Day SMA
34.10
50Day SMA
34.80
100Day SMA
35.00
150Day SMA
34.30
200Day SMA
33.50
Delivery & Volume
Resistance & Support
31.22
Pivot
Resistance
First Resistance
31.78
Second Resistance
32.72
Third Resistance
33.28
Support
First Support
30.28
Second support
29.72
Third Support
28.78
Relative Strength Index
36.69
Money Flow Index
46.18
MACD
-1.03
MACD Signal
-0.71
Average True Range
2.13
Average Directional Index
10.44
Rate of Change (21)
-13.15
Rate of Change (125)
-13.73

Oxygenta Pharmaceutical Ltd Company background

Founded in: 1990
Managing director: Sai Sudhakar Vankineni
Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 202122.The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. The Company is engaged in manufacture of bulk drugs. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and antiinflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company has been doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from QAcid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. To minimize the working capital requirement and to have consistent income, it is necessary to continue contract manufacturing work till the Company gets working capital limits from any Bank. This contract manufacturing helps it to meet major operational expenses of the Company. Since the Company started commercial production in July, 2015 after fire accident, it is in the process of stabilizing the manufacturing and marketing.
Read More

Oxygenta Pharmaceutical Ltd FAQs

The Mutual Fund Shareholding was 0.03% at the end of .

You can easily buy Oxygenta Pharmaceutical Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -